<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Federated Mdt Large Cap Value Fund Class C Shares — News on 6ix</title>
<link>https://6ix.com/company/federated-mdt-large-cap-value-fund-class-c-shares</link>
<description>Latest news and press releases for Federated Mdt Large Cap Value Fund Class C Shares on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 21 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/federated-mdt-large-cap-value-fund-class-c-shares" rel="self" type="application/rss+xml" />
<item>
<title>Humacyte Announces Israeli Ministry of Health Acceptance of Marketing Authorization Application for Symvess® for Vascular Trauma Repair</title>
<link>https://6ix.com/company/federated-mdt-large-cap-value-fund-class-c-shares/news/humacyte-announces-israeli-ministry-of-health-acceptance-of-marketing-authorization-application-for-symvessr-for-vascular-trauma-repair-2</link>
<guid isPermaLink="true">https://6ix.com/company/federated-mdt-large-cap-value-fund-class-c-shares/news/humacyte-announces-israeli-ministry-of-health-acceptance-of-marketing-authorization-application-for-symvessr-for-vascular-trauma-repair-2</guid>
<pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
<description>- The Ministry of Health has set a 180-working-day review period for the MAA - - MAA process is one step in planned expansion of Symvess into multiple</description>
</item>
<item>
<title>BGSF, Inc. Announces Timing of First Quarter Fiscal 2026 Results and Earnings Conference Call</title>
<link>https://6ix.com/company/federated-mdt-large-cap-value-fund-class-c-shares/news/bgsf-inc-announces-timing-of-first-quarter-fiscal-2026-results-and-earnings-conference-call-3</link>
<guid isPermaLink="true">https://6ix.com/company/federated-mdt-large-cap-value-fund-class-c-shares/news/bgsf-inc-announces-timing-of-first-quarter-fiscal-2026-results-and-earnings-conference-call-3</guid>
<pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
<description>PLANO, TX / ACCESS Newswire / April 21, 2026 / BGSF, Inc. (NYSE:BGSF), a growing provider of workforce solutions for the specialized property management</description>
</item>
<item>
<title>DuPont Launches Liveo™ Pharma TPE Overmolded Assemblies for Pharma and Biopharma Applications</title>
<link>https://6ix.com/company/federated-mdt-large-cap-value-fund-class-c-shares/news/dupont-launches-liveotm-pharma-tpe-overmolded-assemblies-for-pharma-and-biopharma-applications-5</link>
<guid isPermaLink="true">https://6ix.com/company/federated-mdt-large-cap-value-fund-class-c-shares/news/dupont-launches-liveotm-pharma-tpe-overmolded-assemblies-for-pharma-and-biopharma-applications-5</guid>
<pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
<description>New customizable assemblies help reduce leakage risk, contamination, and in‑house assembly time and costs for ultrapure fluid transferWILMINGTON, Del., April</description>
</item>
<item>
<title>Textron Aviation Announces Fleet Order From LUMINAIR to Operate Nine Best-selling Cessna Citation Latitude Midsize Business Jets, Supporting Charter Operations Across Europe</title>
<link>https://6ix.com/company/federated-mdt-large-cap-value-fund-class-c-shares/news/textron-aviation-announces-fleet-order-from-luminair-to-operate-nine-best-selling-cessna-citation-latitude-midsize-business-jets-supporting-charter-operations-across-europe-3</link>
<guid isPermaLink="true">https://6ix.com/company/federated-mdt-large-cap-value-fund-class-c-shares/news/textron-aviation-announces-fleet-order-from-luminair-to-operate-nine-best-selling-cessna-citation-latitude-midsize-business-jets-supporting-charter-operations-across-europe-3</guid>
<pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
<description>FRIEDRICHSHAFEN, Germany--(BUSINESS WIRE)-- Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company, today announced at AERO Friedrichshafen it has entered</description>
</item>
<item>
<title>ImmunityBio Announces ANKTIVA® Is Now Available in Saudi Arabia for Bladder and Lung Cancer Patients; Market Entry Achieved Within Two Months of MENA Partnership</title>
<link>https://6ix.com/company/federated-mdt-large-cap-value-fund-class-c-shares/news/immunitybio-announces-anktivar-is-now-available-in-saudi-arabia-for-bladder-and-lung-cancer-patients-market-entry-achieved-within-two-months-of-mena-partnership-9</link>
<guid isPermaLink="true">https://6ix.com/company/federated-mdt-large-cap-value-fund-class-c-shares/news/immunitybio-announces-anktivar-is-now-available-in-saudi-arabia-for-bladder-and-lung-cancer-patients-market-entry-achieved-within-two-months-of-mena-partnership-9</guid>
<pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
<description>ANKTIVA approved for patients with certain indications of non-muscle invasive bladder cancer and non-small cell lung cancer Commercial availability achieved</description>
</item>
<item>
<title>Sun Summit Announces Filing of a NI 43-101 Technical Report on the JD Project, Toodoggone Mining District, B.C.</title>
<link>https://6ix.com/company/federated-mdt-large-cap-value-fund-class-c-shares/news/sun-summit-announces-filing-of-a-ni-43-101-technical-report-on-the-jd-project-toodoggone-mining-district-bc-11</link>
<guid isPermaLink="true">https://6ix.com/company/federated-mdt-large-cap-value-fund-class-c-shares/news/sun-summit-announces-filing-of-a-ni-43-101-technical-report-on-the-jd-project-toodoggone-mining-district-bc-11</guid>
<pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
<description>Vancouver, British Columbia--(Newsfile Corp. - April 21, 2026) - Sun Summit Minerals Corp. (TSXV: SMN) (OTCQB: SMREF) ("Sun Summit" or the "Company") is</description>
</item>
</channel>
</rss>